Compositions and methods for promoting hair growth
Topical compositions with biosurfactants and minoxidil synergistically enhance hair growth and prevent hair loss by improving dermal penetration and promoting fibroblast proliferation, addressing the limitations of existing treatments.
Patent Information
- Application Number
- CN202380031340.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-31
- Filing Date
- 2023-03-31
- Publication Date
- 2024-12-06
AI Technical Summary
Current treatments for hair loss conditions such as alopecia are time-consuming, painful, expensive, and often ineffective, with pharmacological therapies like minoxidil and bimatoprost showing limited effectiveness when used alone.
Topical compositions comprising bioamphiphilic molecules, particularly biosurfactants such as sophorolipids and mannosylerythritol lipids, combined with pharmacological agents like minoxidil, enhance hair growth and prevent hair loss by promoting dermal fibroblast proliferation and improving dermal penetration.
The combination of biosurfactants and minoxidil in topical compositions demonstrates a synergistic effect, effectively promoting hair growth and preventing hair loss, suitable for various causes including alopecia and chemotherapy-induced hair loss.
Smart Images

Figure BDA0005064221240000131 
Figure BDA0005064221240000132
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims priority to U.S. Provisional Patent Application No. 63 / 325,827, filed on March 31, 2022, which is incorporated herein by reference in its entirety. Background Art
[0003] Human hair consists mainly of terminal hair and vellus hair. Terminal hair is a coarse, pigmented, long hair with the bulb or root of the follicle located deep in the dermis. Vellus hair is a fine, thin, non-pigmented, short hair with the bulb of the follicle located superficially in the dermis. At the base of the bulb is the papilla, which contains blood vessels and nerves and provides nutrients to the hair cells to promote growth. The number of papillae is determined at birth and determines the number of hairs present.
[0004] All hair, whether human or animal, goes through a life cycle, a life cycle that consists of three phases, namely the anagen phase, the catagen phase, and the telogen phase. The anagen phase is the period when the hair is actively growing. For example, this usually lasts 3-5 years on the scalp. The catagen phase is the brief transitional phase between the anagen phase and the telogen phase. Again, in terms of the scalp hair life cycle, the catagen phase will last about 1-2 weeks. The final phase is the telogen phase, during which all growth stops and the hair eventually falls out in preparation for new growth. Scalp hair in the telogen phase lasts for about 3-4 months, after which the hair falls out and new hair begins to grow.
[0005] Some individuals experience changes in the hair life cycle and / or hair type that can lead to hair loss. For example, taking certain medications (such as chemotherapy drugs, birth control pills, steroids, and antibiotics) can cause hair loss by interfering with the normal hair life cycle. Some hair loss can be reversed by stopping the medication; however, in some cases, hair loss can be a permanent condition.
[0006] Skin damage and the presence of scar tissue can lead to permanent hair loss, as well as genetic and hormonal causes such as alopecia, or "male pattern baldness." With alopecia, the scalp begins to lose hair at the temples and on the top of the head. This incurable condition is primarily limited to men, but is occasionally observed in women as well.
[0007] As alopecia progresses, the hairs themselves change from terminal hairs to vellus hairs. In addition, as alopecia occurs, more and more hairs are in the telogen phase, and correspondingly fewer hairs are in the actively growing anagen phase. Alopecia is also associated with a severe reduction in hair follicles, for example, a reduction of about one-third or more. Therefore, it is this combination of factors that leads to baldness: the transformation of hairs from terminal hairs to vellus hairs, an increase in the number of telogen hairs (some of which are already lost), and a reduction in hair follicles and their loss.
[0008] One known treatment for alopecia is hair transplantation. Transplanting pieces of skin containing hair from areas of the scalp where hair grows to bald areas has been quite successful; however, the procedure is not only time-consuming and painful, but also expensive. Other non-drug related treatments include, for example, ultraviolet light exposure, massage, psychotherapy, revascularization surgery, acupuncture, and exercise therapy. However, none of these methods are generally considered effective.
[0009] To date, the most common treatment for alopecia is pharmacological therapy. For example, the use of microcreams containing estradiol and oxandrolone as their active ingredients and the use of silicones have proven to be useful. In addition, the compounds bimatoprost and minoxidil can be used to stimulate hair growth and / or prevent hair loss.
[0010] Bimatoprost is an ophthalmic drug used to treat high eye pressure, glaucoma, and to increase eyelash length. Typically, bimatoprost is administered as liquid eye drops.
[0011] Minoxidil treats severe hypertension by dilating the peripheral vasculature. Dermatologists recognize that long-term vasodilation in certain areas of the body (other than the scalp) can sometimes lead to increased hair growth, even in the absence of any vasodilator therapeutic agents. For example, it is not uncommon to see increased hair growth around surgical scars. Similarly, arteriovenous fistulas are known to result in an increased vascular supply with concurrent increased hair growth. First introduced as an oral medication for the treatment of hypertension, topical solutions and foam products containing minoxidil were introduced to prevent or treat hair loss. Summary of the invention
[0012] The present invention provides topical therapeutic compositions for enhancing the health of the skin, scalp and hair. More specifically, the present invention provides compositions and methods for promoting hair growth and / or treating hair loss using microbial growth byproducts. Advantageously, these compositions and methods can be used in subjects experiencing hair loss due to a variety of causes, including alopecia and / or chemotherapy.
[0013] In certain embodiments, the present invention provides topical compositions for promoting hair growth, the compositions comprising one or more bioamphiphilic molecules. In certain embodiments, the topical compositions comprise one or more bioamphiphilic molecules in combination with a pharmacological or naturopathic hair growth promoter.
[0014] In a preferred embodiment, the bioamphiphilic molecule is a biosurfactant selected from, for example, low molecular weight glycolipids (e.g., sophorolipids, rhamnolipids, cellobiose lipids, mannosylerythritol lipids and trehalose lipids), lipopeptides (e.g., surfactin, iturin, fengycin, anthrofactin and lichenin), yellow lipids, phospholipids (e.g., cardiolipin), fatty acid ester compounds, fatty acid ether compounds and high molecular weight polymers (e.g., lipoproteins, lipopolysaccharide-protein complexes and polysaccharide-protein-fatty acid complexes).
[0015] The one or more biosurfactants may also include any one or a combination of: modified forms, derivatives, fractions, isoforms, isomers or subtypes of biosurfactants, including biologically or synthetically modified forms. In certain embodiments, the biosurfactant is a biosurfactant in salt form.
[0016] In certain specific embodiments, the biosurfactant is a glycolipid, more specifically a sophorolipid (SLP) and / or a mannosylerythritol lipid (MEL). In certain embodiments, a combination of SLP and MEL is used.
[0017] In certain embodiments, biosurfactants can be used as active ingredients in topical compositions to promote hair growth and / or prevent hair loss. For example, in some embodiments, biosurfactants can enhance dermal fibroblast proliferation and / or function, and / or can accelerate papillary cell and hair growth.
[0018] In certain embodiments, biosurfactants can be used as adjuvants and / or additives that can enhance dermal penetration of active and inactive ingredients in a composition (e.g., pharmacological or naturopathic hair growth promoters), and / or enhance formulation of the composition (e.g., by enhancing emulsification).
[0019] In certain embodiments, the pharmacological hair growth promoting agent of the compositions of the present invention is minoxidil or bimatoprost.
[0020] In certain exemplary embodiments, the topical composition of the present invention comprises SLP, MEL and minoxidil. Advantageously, the composition having this combination of ingredients has a surprising synergistic effect in promoting hair growth compared to each ingredient alone.
[0021] In some embodiments, the composition comprises a live or inactivated microorganism, its growth byproducts and / or a culture supernatant of the microorganism. In certain embodiments, the microorganism is a yeast, such as Starmerella bombicola, Wickerhamomyces anomalus NRRL Y-68030, Meyerozyma guilliermondii and / or Pseudozyma aphidis. In certain embodiments, the microorganism is a bacterium, such as Bacillus coagulans, Bacillus amyloliquefaciens NRRL B-67928 or Bacillus subtilis B4 NRRL B-68031.
[0022] In some embodiments, the topical composition may further comprise a dermatologically acceptable carrier, such as a water-in-oil or oil-in-water emulsion, or an aqueous serum.
[0023] In some embodiments, the topical compositions may also include adjuvants and additives commonly found in topical skin and hair care compositions, such as organic solvents, silicones, stabilizers, thickeners, humectants, conditioning agents, surfactants, colorants, fragrances, pH adjusters, buffers, local anesthetics, anti-biofilm agents, anti-fungal agents, vitamins, minerals, botanicals, extracts, essential oils, retinoids, anti-acne agents, moisturizers, sunscreens, and / or other therapeutic and non-therapeutic components known to be useful, for example, for healing, replenishing, rejuvenating, moisturizing, protecting and / or improving the skin and scalp and stimulating and hair growth.
[0024] In certain embodiments, the present invention provides methods for promoting hair growth, wherein the topical compositions of the present invention are applied directly to an area of the skin of a subject where hair loss and / or hair growth is desired. In some embodiments, the topical compositions are formulated and applied as a cream, lotion, ointment, gel, paste, serum, tonic, spray, aerosol, solid stick, eye drops, or oil, wherein the formulation is suitable for application to the skin of, for example, the scalp, eyelids, face, extremities, or trunk.
[0025] In some embodiments, the method can enhance scalp health, prevent hair loss, and / or stimulate hair growth in a subject in need thereof. In some embodiments, the subject experiences hair loss due to pattern hair loss, chemotherapy, skin injury, burns, scarring, or a side effect of a drug.
[0026] In certain embodiments, the method may further include applying an additional composition to enhance hair growth and / or supplement the activity of the topical composition as part of a hair growth regimen. For example, in one embodiment, the method may include cleaning the scalp or other skin area experiencing hair loss with a cleansing composition comprising a mixture of SLP and MEL.
[0027] In certain embodiments, the application of topical compositions and / or cleansers may also be supplemented by the administration of oral compounds such as DHT (dihydrotestosterone) blockers. In certain embodiments, subjects with pattern hair loss experience shrinkage of hair follicles due to the binding of DHT to the hair follicles; therefore, in some embodiments, DHT blockers may help prevent hair loss through this mechanism.
[0028] Advantageously, in some embodiments, use of a multi-part regimen may provide more lasting consistent results for subjects experiencing hair loss. DETAILED DESCRIPTION
[0029] The present invention provides topical therapeutic compositions for enhancing skin, scalp and hair health. More specifically, the present invention provides compositions and methods for promoting hair growth and / or treating hair loss using microbial growth byproducts. Advantageously, these compositions and methods can be used for subjects experiencing hair loss due to a variety of causes, including alopecia and / or chemotherapy.
[0030] Selected Definitions
[0031] Plant "extracts" as used herein refer to materials obtained by exposing plant parts to solvents and removing the solvent or using various chemical, immunological, biochemical or physical steps known to those skilled in the art, including but not limited to precipitation, steam distillation, centrifugation, filtration, column chromatography, detergent lysis and cold pressing (or squeezing). Plant extracts can include, for example, essential oils. Plant material can include a part of a plant, including fruit, roots, stems, leaves, flowers or parts thereof.
[0032] As used herein, the term "probiotic" refers to a microorganism that, when administered in adequate amounts, can confer a health benefit on the host. In certain embodiments, the probiotic is administered to the digestive tract of a subject to confer, for example, a digestive benefit on the subject.
[0033] The terms "naturopathic," "natural," and "naturally derived," when used in the context of a chemical compound or substance, refer to a material found in nature, meaning it is produced by earth processes or by living organisms. A natural product may also be isolated or purified from its natural source and used or incorporated into a variety of applications, including foods, beverages, cosmetics, and supplements. Thus, natural products may be combined with other natural products or with non-natural products that do not occur in nature. Natural products may also be produced in a laboratory by chemical synthesis, as long as no artificial components or ingredients (i.e., synthetic ingredients that are not found naturally as products of the earth or living organisms) are added.
[0034] As used herein, the terms "cure" and / or "amend" a condition or disorder refers to eradication, alleviation, improvement, or reversal of the signs or symptoms of the condition or disorder to any extent, and includes, but is not limited to, complete cure of the condition or disorder.
[0035] As used herein, "preventing" a condition or disorder means avoiding, delaying, forestalling, or minimizing the onset of specific signs or symptoms of the condition or disorder. Prevention can be absolute or complete, but need not be, meaning that the signs or symptoms may still develop in the future. Prevention can include reducing the severity of the onset of such condition or disorder, and / or inhibiting the progression of a condition or disorder to a more severe condition or disorder.
[0036] According to the present invention, "promoting" hair growth means enhancing or accelerating the rate of hair growth, and / or creating conditions at the site of hair loss that are conducive to increased hair growth. In some embodiments, this can be achieved by changing the hair life cycle, such as increasing the growth phase or anagen phase and / or reducing the resting phase. Hair growth can include increasing hair length, increasing hair thickness, increasing hair strength, and increasing hair quantity. In some embodiments, promoting hair growth can also include preventing and / or slowing down hair loss.
[0037] As used herein, the term "wound" refers to tissue damage caused by, for example, a cut, blow or other impact. According to the present invention, wounds include skin injuries (classified as "open wounds"), including, for example, cuts, abrasions, ulcers, lesions, scrapes, crushes, punctures, tears, burns, lacerations, incisions, gunshot wounds, bites, punctures and avulsions.
[0038] As used herein, the term "burn" refers to a wound caused by heat (hot or cold), chemical (e.g., from acid or alkali), friction, radiation (e.g., sunburn or ultraviolet light), or an electrical source. Burns may be "mild" burns, including first degree burns, which are superficial injuries to the outer dermis, and second degree burns, where the damage extends down to the epidermal cell layer. Symptoms of burns include, for example, irritation, blistering, itching, peeling, rash, redness, and swelling.
[0039] As used herein, the term "scar" refers to a mark or growth on the skin where an injury (e.g., a wound, burn, sore, surgical incision, or puncture) has not healed properly and fibrous connective tissue has developed in place of normal tissue. Scars can include hypertrophic scars, in which overproduction of collagen forms a raised area of tissue above the surrounding skin; keloids, another form of excessive scarring, in which tissue forms a large, protruding growth; atrophic scars, in which the underlying structural tissue is lost, resulting in a pitted or sunken appearance (e.g., acne scars); and stretch marks, which are caused by rapid stretching of the skin during, for example, pregnancy, growth spurts, or skin regeneration.
[0040] As used herein, the term "subject" refers to an animal, preferably a mammal. In the context of the present invention, the preferred subject is a human. The subject can be of any gender, any age or developmental stage, including infants, young children, adolescents, teenagers, young adults, middle-aged or elderly.
[0041] As used herein, "topical" means suitable for topical application to the skin or skin application. In some embodiments, "topical" may include ocular application, including application to the eyelids.
[0042] As used herein, "dermatologically acceptable", "cosmetically acceptable", and "acceptable for topical use" are used interchangeably and are intended to mean that the particular components are safe and non-toxic for application to the integument (e.g., skin) at the levels used. In one embodiment, the components of the composition are considered "generally recognized as safe (GRAS)".
[0043] As used herein, the terms "therapeutically effective amount," "effective amount," and "effective dose" are used to refer to an amount of something (e.g., a compound, a composition, time) that is capable of achieving the desired amount of hair growth in a subject. The actual amount will vary depending on a variety of factors, including, but not limited to, the specific condition or disorder causing hair loss, the severity of the condition, the size, age, and health of the subject, and the mode of administration.
[0044] As used herein, "microbial-based compositions" refers to compositions that include components produced by the growth of microorganisms or other cell cultures. Thus, microbial-based compositions can include the microorganisms themselves and / or byproducts of microbial growth (e.g., biosurfactants, solvents, and / or enzymes). Cells can be in a vegetative state or in spore form, or a mixture of the two. Cells can be in planktonic or biofilm form, or a mixture of the two. Cells can be alive or inactive, intact or lysed. Cells can be removed from the medium in which they were grown, or present at a concentration, for example, of at least 1 x 10 3 , 1x 10 4 , 1x 105 , 1x 10 6 , 1x 10 7 , 1x 10 8 , 1x 10 9 , 1x 10 10 or 1x10 11 In one embodiment, the composition based on a microorganism may only contain a culture medium in which the cells are grown, wherein the cells are removed (although in some cases, some residual cell material may also remain in the culture medium). Growth byproducts may be present in the culture medium and may include, for example, metabolites, cell membrane components, expressed proteins, and / or other cellular components. In one embodiment, the composition based on a microorganism only contains microbial growth byproducts.
[0045] The present invention also provides "microorganism-based products", which are products for practice to achieve the desired results. Microorganism-based products can simply be compositions based on microorganisms harvested from microbial culture processes. Alternatively, microorganism-based products can include other ingredients that have been added. These additional ingredients can include, for example, stabilizers, buffers, carriers and other additives and / or adjuvants suitable for specific applications. Microorganism-based products can also include mixtures based on microorganism-based compositions. Microorganism-based products can also include one or more components of compositions based on microorganisms that have been processed in some way (for example, but not limited to filtration, centrifugation, lysis, drying, purification, etc.).
[0046] "Metabolite" refers to any substance produced by metabolism (e.g., a growth byproduct) or a substance necessary to participate in a specific metabolic process. Examples of metabolites include, but are not limited to, enzymes, acids, solvents, alcohols, proteins, carbohydrates, vitamins, minerals, trace elements, amino acids, polymers, and biosurfactants.
[0047] As used herein, the terms "isolated" or "purified" when used in connection with biological or natural materials (e.g., nucleic acid molecules, polynucleotides, polypeptides, proteins, organic compounds (e.g., small molecules), microbial cells / strains, or host cells) refer to materials that are substantially free of other compounds (e.g., cellular material) with which they are associated in nature. That is, these materials do not occur naturally without these other compounds and / or have different or unique properties than those found in the natural material.
[0048] In certain embodiments, the purified compound comprises at least 60% by weight of the target compound. Preferably, the preparation comprises at least 75%, more preferably at least 90%, and most preferably at least 99% or 100% (w / w) of the desired compound by weight. Purity can be measured by any appropriate standard method, such as by column chromatography, thin layer chromatography, or high performance liquid chromatography (HPLC) analysis.
[0049] As used herein, "isomer" refers to a molecule having the same chemical formula as another molecule but having a unique structure. Isomers can be structural isomers, in which atoms and functional groups are bonded in different positions, or stereoisomers (stereoisomers), in which the bond structure is the same but the geometric positions of the atoms and functional groups in space are different. For example, MEL isomers can differ in the type and position of bonds to carbohydrates, fatty acids, and / or acetyl groups.
[0050] As used herein, "surfactant" refers to a surface-active substance or a compound that reduces the surface tension (or interfacial tension) between two phases. Surfactants are used, for example, as detergents, wetting agents, emulsifiers, foaming agents and / or dispersants. "Biosurfactant" refers to a surfactant produced by a living organism, and / or a surfactant produced using a naturally derived substrate.
[0051] The transitional term "comprising," which is synonymous with "including" or "containing," is inclusive or open-ended and does not exclude additional, unrecited elements or method steps. In contrast, the transitional phrase "consisting of" excludes any elements, steps, or ingredients not specified in the claim. The transitional phrase "consisting essentially of" limits the scope of the claim to the specified materials or steps "and those that do not materially affect the basic and novel characteristics of the claimed invention." The use of the term "comprising" contemplates other embodiments of "consisting of" or "consisting essentially of."
[0052] Unless expressly stated or obvious from the context, as used herein, the term "or" should be construed as inclusive. Unless expressly stated or obvious from the context, as used herein, the terms "a", "an" and "the" should be construed as singular or plural.
[0053] Unless expressly stated or obvious from the context, as used herein, the term "about" should be understood as within the normal tolerance range in the art, such as within 2 standard deviations of the mean. "About" can be understood as within 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.05% or 0.01% of the stated value.
[0054] In any definition of a variable herein, the recitation of a list of chemical groups includes defining the variable as any single group or combination of the listed groups. The recitation of an embodiment of a variable or aspect herein includes the embodiment as any single embodiment or in combination with any other embodiment or portion thereof.
[0055] Any composition or method provided herein can be combined with one or more of the other compositions and methods provided herein. Other features and advantages of the present invention will be apparent from the following description of its preferred embodiments and the claims. All references cited herein are hereby incorporated by reference.
[0056] Topical hair growth compositions
[0057] In certain embodiments, the present invention provides topical compositions for promoting hair growth comprising one or more bioamphiphilic molecules in combination with a pharmacological or naturopathic hair growth promoting agent.
[0058] In a preferred embodiment, the bioamphiphilic molecule is a biosurfactant selected from, for example, low molecular weight glycolipids (e.g., sophorolipids, rhamnolipids, cellobiose lipids, mannosylerythritol lipids and trehalose lipids), lipopeptides (e.g., surfactin, iturin, fengycin, arthritisin and lichenin), yellow lipids, phospholipids (e.g., cardiolipin), fatty acid ester compounds, fatty acid ether compounds and high molecular weight polymers (e.g., lipoproteins, lipopolysaccharide-protein complexes and polysaccharide-protein-fatty acid complexes).
[0059] Biosurfactants are amphiphiles, which means they contain both polar (hydrophilic) and nonpolar (hydrophobic) groups. Due to their amphiphilic structure, biosurfactants reduce surface tension and interfacial tension between liquid, solid and gas molecules.
[0060] In addition, biosurfactants aggregate at interfaces, resulting in the formation of aggregated micellar structures in solution. The ability of biosurfactants to form pores and disrupt biofilms makes them useful as, for example, antibacterial and antifungal agents, as well as delivery agents for other compounds such as across membranes. In addition, biosurfactants are biodegradable, have low toxicity, and can be produced using low-cost renewable resources. They can inhibit the adhesion of microorganisms to various surfaces, prevent the formation of biofilms, and have strong emulsification and demulsification properties.
[0061] The one or more biosurfactants may also include any one or a combination of: modified forms, derivatives, fractions, isoforms, isomers or subtypes of biosurfactants, including biologically or synthetically modified forms. In one embodiment, the one or more biosurfactants are present in the composition at a critical micelle concentration (CMC).
[0062] In some embodiments, the amphiphilic molecules are used in a crude form, wherein the molecules are present in a growth medium (e.g., broth) in which the amphiphilic microorganisms are cultured and collected without purification. The crude form may include, for example, at least 0.001%, 1%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% or 99% of the amphiphilic molecules in the growth medium. In alternative embodiments, the amphiphilic molecules are purified from the culture product.
[0063] In certain embodiments, biosurfactants can be used as active ingredients in topical compositions for promoting hair growth and / or preventing hair loss. For example, in some embodiments, biosurfactants can enhance dermal fibroblast proliferation and / or function, and / or can accelerate papillary cell and hair growth. In some embodiments, biosurfactants according to the present invention can also achieve one or more of the following: killing pathogens in / on the skin / scalp, modulating the skin's immune system, killing melanocytes to allow replacement cells to grow, and reducing oxidative stress.
[0064] In certain embodiments, biosurfactants can be used as adjuvants and / or additives that can enhance dermal penetration of active and inactive ingredients in a composition (e.g., a pharmacological or naturopathic hair growth promoter) and / or enhance formulation of the composition, for example, by enhancing emulsification.
[0065] In a preferred embodiment, the biosurfactant is a sophorolipid (SLP) and / or a mannosylerythritol lipid (MEL), which are glycolipid biosurfactants produced by certain yeasts. Glycolipids typically comprise a monosaccharide or oligosaccharide group attached to a sphingolipid or glycerol group that may be acetylated or alkylated, and one or more fatty acids.
[0066] SLP is produced by, for example, Candida clade yeasts (including Candida albicans and Candida spp. bumblebee). In some embodiments, Wickham's yeast is a SLP producer (e.g., Wickham's yeast NRRL Y-68030). SLP consists of the disaccharide sophorose connected to long-chain hydroxy fatty acids. These SLPs are partially acetylated 2-O-β-D-glucopyranosyl-D-glucopyranose units connected to 17-L-hydroxyoctadecanoic acid or 17-L-hydroxy-Δ9-octadecenoic acid by β-glycosides. Hydroxy fatty acids typically have 16 or 18 carbon atoms and may contain one or more unsaturated bonds. The fatty acid carboxyl group may be free (acidic or open form) or esterified internally at the 4″-position (lactone form).
[0067] SLP has environmental compatibility, high biodegradability, low toxicity, high selectivity and specific activity under a wide range of temperature, pH and salinity conditions. In addition, in some embodiments, SLP is beneficial for cosmetic and dermatological applications due to its small micelle size, which helps to promote the movement of micelles and their encapsulated compounds through nanoscale pores and spaces (e.g., between epithelial cells and into biofilm matrices). In certain embodiments, the micelle size of SLP is less than 100nm, less than 50nm, less than 20nm, less than 15nm, less than 10nm or less than 5nm.
[0068] In certain embodiments, the SLP according to the present invention is represented by the general formula (1) and / or the general formula (2), and is a fatty acid having different chain lengths (R 3 ) and in some cases in R 1 and / or R 2 The resulting protein was obtained from a collection of 30 or more structural homologues with acetylation or protonation at the 3 positions.
[0069]
[0070] In the general formula (1) or (2), R 0 It can be a hydrogen atom or a methyl group. 1 and R 2 are each independently a hydrogen atom or an acetyl group. 3 It is a saturated aliphatic hydrocarbon chain or an unsaturated aliphatic hydrocarbon chain having at least one double bond, and may have one or more substituents.
[0071] Non-limiting examples of the substituent include a halogen atom, a hydroxyl group, a lower (C1-6) alkyl group, a halogenated lower (C1-6) alkyl group, a hydroxy lower (C1-6) alkyl group, a halogenated lower (C1-6) alkoxy group, and the like. 3 It generally has 11 to 20 carbon atoms, preferably 13 to 17 carbon atoms, and more preferably 14 to 16 carbon atoms.
[0072]
[0073] In certain embodiments, the SLP according to the present invention is a salt form SLP represented by the general formula (3), wherein R 4 =metal ion, such as Na, K, Mg, Cu or Ca.
[0074] Advantageously, SLPs can have a variety of benefits as active or inactive ingredients in topical compositions. These can include, for example, emulsifying oil-in-water or water-in-oil mixtures; reducing inflammation and oxidative stress; removing damaged keratinocytes from the upper layers of the skin; enhancing wound healing through antimicrobial and anti-inflammatory effects; promoting fibroblast metabolism; improving collagen synthesis and toning / remodeling the skin; stimulating leptin synthesis by adipocytes and helping to reduce subcutaneous fat overload that causes cellulite; inhibiting elastase activity and reducing the appearance of wrinkles; desquamating and depigmenting spots on the skin and inhibiting melanogenesis; controlling microbial dandruff, acne, and body odor; and / or reducing inflammatory conditions such as dermatitis, eczema, and psoriasis.
[0075] In certain preferred embodiments, the SLP comprises a mixture of lactone and linear SLP, such as a mixture of SLPs according to formula (1) and (2). In some embodiments, the ratio of lactone to linear SLP is 50:50 to 10:90, 40:60 to 20:80, or about 30:70 (lactone: linear).
[0076] In one embodiment, glycolipid is MEL.MEL comprises 4-OBD-mannopyranosyl-meso-erythritol or 1-OBD-mannopyranosyl-meso-erythritol as hydrophilic part, and fatty acid group and / or acetyl group as hydrophobic part.One or two hydroxyl groups (usually at C4 and / or C6 place of mannose residue) can be acetylated.In addition, there can be one to three esterified fatty acids, and 8 to 12 carbons or more are arranged on chain length.
[0077] MEL and MEL-like substances (e.g., mannosyl substances) are mainly produced by Pseudomonas and Ustilago, and there are significant differences between the structures of MEL produced by each species. Pichia guilliermondii can also produce certain mannosyl substances with properties similar to MEL.
[0078] MEL is non-toxic and stable over a wide range of temperature and pH. In addition, MEL can be used without any additional preservatives.
[0079] MEL can be produced in more than 93 different combinations, which are divided into 5 main categories: MEL A, MEL B, MEL D, triacetylated MEL A and triacetylated MEL B / C. These molecules can be modified synthetically or naturally. For example, MEL can contain chains of different carbon lengths or different numbers of acetyl and / or fatty acid groups.
[0080] The MEL molecule and / or its modified form according to the present invention may include, for example, triacylated, diacylated, monoacylated, triacetylated, diacetylated, monoacetylated and non-acetylated MEL, and stereoisomers and / or constitutional isomers thereof.
[0081] According to the present invention, other mannosyl substances / MEL-like substances exhibiting similar structures and similar properties may also be used, for example, mannosyl-mannitol lipids (MML), mannosyl-arabinitol lipids (MAL) and / or mannosyl-ribitol lipids (MRL).
[0082] Advantageously, MEL has a variety of benefits as an active or inactive ingredient in a topical composition. These benefits may include, for example: reducing skin inflammation; preventing cell damage caused by the use of synthetic surfactants (e.g., SDS); stimulating hair follicle bulb cells and hair growth; repairing and / or strengthening damaged hair (particularly, such as MEL-A and MEL-B); increasing the activity of fibroblasts and papillary cells (particularly, such as MEL-A); reducing sweating and assisting the functioning of the skin moisture barrier; and / or reducing the melanin content in age spots.
[0083] In certain preferred embodiments, the topical compositions of the present invention comprise a mixture of SLP and MEL.
[0084] In preferred embodiments, the concentration of the SLP relative to the total topical composition is about 100 to 500 ppm, about 125 to 375 ppm, about 150 to 300 ppm, about 180 to 250 ppm, or about 200 ppm.
[0085] In preferred embodiments, the concentration of MEL (or MEL-like substances) relative to the total topical composition is 0.01 to 100 ppm, about 1 to 75 ppm, about 2 to 50 ppm, about 3 to 25 ppm, about 5 to 10 ppm, about 4 to 6 ppm, about 5 ppm or 5 ppm or less.
[0086] In one embodiment, the biosurfactant may include one or more lipopeptides, for example, surfactin, iturin, fengycin, arthrocin, mucin, amphotericin, syringomycin, and / or lichenin.
[0087] In certain embodiments, the lipopeptide biosurfactant is a surfactant. Lipopeptides are produced by a variety of probiotics and non-pathogenic bacteria (e.g., Bacillus natto, Bacillus coagulans, Bacillus subtilis, Bacillus amyloliquefaciens, lactic acid bacteria, etc.). In some embodiments, the lipopeptide is produced by a specific strain of Bacillus (e.g., Bacillus amyloliquefaciens NRRL B-67928 or Bacillus subtilis B4 NRRL B-68031).
[0088] In certain embodiments, the compositions according to the present invention further comprise one or more pharmacological or naturopathic hair growth promoters, including, for example, minoxidil, bimatoprost, finasteride, dihydrotestosterone, biotin, fibroblast growth factor, keratinocyte growth factor, basic fibroblast growth factor, platelet-derived growth factor, spironolactone, vitamins and minerals (e.g., vitamin B, vitamin E, vitamin A, vitamin C, vitamin D, iron, folic acid, zinc), retinol, collagen peptides, omega-3, omega-6 and omega-9 fatty acids. , plant extracts (e.g., from citrus lemon, strawberry, rye, epimedium, geranium, olive, wild tea tree, Arabica coffee tree, safflower, ginseng, houttuynia, sophora flavescens, Japanese mangosteen, star anise, barley, lotus seeds, cypress, polygonum multiflorum, liaotung alder, wild sunflower, magnolia bark, Korean angelica, sappan wood, paper mulberry, cypress, sweet potato, leafy iron nail vegetable, light walnut, cloud wood fragrance, dogwood, anemarrhena, lychee grass, ribless peterseniana kelp, kudzu, cypress, polygonum multiflorum, rosemary, white bone soil, brown algae, saw palmetto, etc.), and Bioactive compounds (e.g., sinapic acid, icariin, corilagin, gallic acid, oleuropein, caffeine, hydroxysafflor yellow A, linoleic acid, β-sitosterol, quercetin, L-galactotin, meditartin, shikimic acid, proanthocyanidins (including B2 and B3), ginsenoside Rb1, anthraquinone, flavonoids, tannins, saponins, α-terpinenyl acetate, sabinene, isobornyl acetate, limonene, β-D-glucoside, rhubarb, oregonin, myristoleic acid, lipopolysaccharide, purpurogenol, 3-deoxysuccinic acid) Ketone, 7-hydroxycoumarin, protocatechuic acid, ferulic acid, protocatechuic acid, epicatechin, β-sitosterol, kaempferol, isoquercetin, octaphlorethol A, vitamin E, oleic acid, costunolactone, morroniside, anemarrhena saponin BII, phenolic acid, terpenes, terpenoids, saponins, myricetin, isoquercetin, quercetin, myricetin, afudanoside, quercetin, kaempferol, amentoflavone, cypress biflavonoids, ginsenoside Ro, rhyscion, aviquinone C, dieckol, etc.).
[0089] In certain embodiments, a pharmacological or naturopathic hair growth promoting agent is a compound that can stimulate a quiescent hair follicle (telogen) to a growing hair follicle (anagen) (eg, anagen extension).
[0090] In some embodiments, the pharmacological or naturopathic hair growth promoting agent is a compound that can promote growth factor expression, reduce inflammatory cytokines, activate Wnt / β-catenin signaling, promote hedgehog pathway signaling (Shh), inhibit 5α-reductase and / or improve cell cycle progression.
[0091] In a specific embodiment, the pharmacological hair growth promoter is minoxidil.
[0092] In certain embodiments, the pharmacological or naturopathic hair growth promoting agent is present in the topical composition at a concentration of 0.001% to 90%, 0.01% to 50%, 0.05% to 10%, or about 5% by weight of the total composition.
[0093] In certain exemplary embodiments, the topical composition of the present invention comprises SLP, MEL and minoxidil. Advantageously, the composition having this combination of ingredients has a surprising synergistic effect in promoting hair growth compared to each ingredient alone.
[0094] In certain embodiments, in addition to having therapeutic benefits in themselves, biosurfactants can also help increase the transdermal absorption of minoxidil to enhance benefits, such as changing the hair growth phase and hair thickness. In certain embodiments, biosurfactants can form micelles, liposomes, or vesicles around minoxidil to enhance its absorption through the skin. In certain embodiments, biosurfactants can be combined with minoxidil to promote its absorption through the skin.
[0095] In a specific example, the composition comprises 200 ppm SLP, 5 ppm MEL, and 5% minoxidil, wherein the SLP comprises a ratio of linear SLP to lactone SLP of 70:30.
[0096] In some embodiments, the topical compositions of the present invention comprise live or inactivated microorganisms capable of producing growth byproducts useful for hair growth, skin healing and regeneration, and / or supernatants derived from the culture of such microorganisms. In certain embodiments, the microorganism is a yeast, such as Bombyx mori, Wickham's yeast (e.g., NRRL Y-68030), Pichia guillemot (Pichia spp.), and / or Pseudomonas aphidoides. In a specific embodiment, the composition comprises live or inactivated Wickham's yeast.
[0097] In certain embodiments, the microorganism is a bacterium, such as Lactobacillus, Bifidobacterium, Lactococcus, Streptococcus and Bacillus, for example, Bacillus acidofast, Bacillus acidoliving, Bacillus acidogenic, Bacillus acidocalorum, Bacillus acidofast, Bacillus aeolus, Bacillus aerophilus, Bacillus aerophilus, Bacillus agglutinosa, Bacillus soil, Bacillus aidingensis, Bacillus akibai, Bacillus alkaliphilus, Bacillus algaeliving, Bacillus alginolyticus, Bacillus diazotrophicus, Bacillus alkaline nitrogen, Bacillus alkaline sediment, Bacillus alkaline earth, Bacillus highland, Bacillus amyloliquefaciens, Bacillus alveolar, Bacillus amyloliquefaciens, Bacillus amyloliquefaciens subsp. amyloliquefaciens, Bacillus plantarum, Bacillus amylolyticus, Bacillus andresenii, Bacillus thiamine lyticus, Bacillus anthracis, Bacillus marine, Bacillus sandii, Bacillus arsenicoselenium, Bacillus arsenicum, Bacillus aurantium, Bacillus field, Bacillus aryabdominis, Bacillus asahi, Bacillus atrophaeus, Asarki Bacillus subtilis, Bacillus azotobacter, Bacillus azotobacter, Bacillus chestnut brown, rare Bacillus, Bacillus Batavia, Bacillus Beijing, Bacillus benzimidazole, Bacillus Bering Sea, Bacillus Berkeley, Bacillus Beveridge, Bacillus Bogoria, Bacillus boronophilic, Bacillus Potssteine, Bacillus brevis, Bacillus butyric acid, Bacillus Canaveral, Bacillus carbonophilic, Bacillus cixi (B.cecembensis), Bacillus cellulolyticus, Bacillus neusporus, Bacillus cereus, Bacillus chagannoul, Bacillus lycopersicum, Bacillus cerus, Bacillus cerevisiae, Bacillus cerevisiae Bacillus butyricum, Bacillus chondroitinus, Bacillus chondroitinus, Bacillus chang'an, Bacillus food, Bacillus circulans, Bacillus kluyveri, Bacillus clausii, Bacillus coagulans, Bacillus coagulans, Bacillus coagulans, Bacillus cycloheptane, Bacillus cytotoxin, Bacillus darius, Bacillus rotten leaves, Bacillus decolorization, Bacillus desert, Bacillus lizard, Bacillus drenthe, Bacillus soil, Bacillus eihime, Bacillus earthworm, Bacillus sea urchin, Bacillus endophyticus, B.endoradicis, Bacillus mixed, Bacillus fastidious, Bacillus sealed, Bacillus firmus, Bacillus flexus, Bacillus microporus, Bacillus fordy, Bacillus beautiful, Bacillus strong, Bacillus fulmarioli, Bacillus rope-shaped, Bacillus spindle, Bacillus galactophilus, Bacillus galactolyticus, Bacillus galicianus, Bacillus gelatinous, Bacillus gibsonii, Bacillus ginseng, Bacillus ginseng soil, Bacillus ginseng soil, Bacillus sphaeroides, Bacillus sphaeroides, Bacillus sphaeroides subsp. sphaeroides, Bacillus sphaeroides marine subsp. sphaeroides, Bacillus gordonii, Bacillus gordonii, Bacillus graminearum, Bacillus halosusceptible, Bacillus halophilus, Bacillus halozoon, Bacillus halodesus, Bacillus nitrosporus, Bacillus halophilus, Bacillus halophilus, Bacillus halophilus, Bacillus hemicellulose, Bacillus halophilus, Bacillus niger ... Bacillus, Lactobacillus, Bacillus larvae, Bacillus laterosporus, Bacillus radiata, Bacillus Leh, Bacillus lentus, Bacillus lentus, Bacillus licheniformis, Bacillus lignophilus, Bacillus seaside, Bacillus halogenus, Bacillus lucifera, Bacillus light yellow, Bacillus yolk, Bacillus macau, Bacillus softening, Bacillus maquary, Bacillus machae (B.macyae), Bacillus malaga, Bacillus mannitol saccharolyticus, Bacillus yellow sea, Bacillus dead sea, Bacillus Mayer Mayer Island, Bacillus Marseille, Bacillus megaterium, Bacillus cereus, Bacillus methanolicus, Bacillus methylotrophicus, Bacillus migulanus, Bacillus mojave Bacillus, Bacillus colloids, Bacillus wall, Bacillus Martini, Bacillus mycoides, Bacillus Nagano, Bacillus Nanhai, Bacillus Nanhai sediment, Bacillus nealsonii, Bacillus nerii, Bacillus Leizhou, Bacillus Agricultural Research Institute, Bacillus nicotinic acid, Bacillus Novalis, Bacillus Odyssey, Bacillus Ohana, Bacillus Ohida, Bacillus vegetable, Bacillus rice shell, Bacillus Oshima, Bacillus feed, Bacillus Pakistani, Bacillus paleo, Bacillus paleo, Bacillus ginseng soil, Bacillus ginseng land, Bacillus pantothenic acid, Bacillus parabrevis, Bacillus acuminata, Bacillus pasteurianus (B.pasteurii), Patagonian Bacillus, Pierreurii Bacillus, Persian Bacillus, Persian Bacillus, Pervagian Bacillus, Sponge Bacillus, Pocheon Bacillus, Multilateral Bacillus, Polymyxa Bacillus, Japanese Beetle Bacillus, Pseudo-alkaliphilic Bacillus, Pseudomonas firmus, Pseudomonas fungiformis, Psychrotolerant Bacillus, Psychrotrophic Bacillus, Psychrolytic Bacillus, Psychrotolerant Bacillus, Dust Bacillus, Bacillus brevis, Anti-purification Bacillus, Firmicutes Bacillus, Qingdao Bacillus, Qingsheng Bacillus, Reuteri (B. reuszeri), rhizosphere Bacillus, well water Bacillus, farm Bacillus, Shafu Bacillus, halobacillus, halobacillus, halobacillus, halophilic Bacillus, schlegelii, sediment Bacillus, selenium arsenic Bacillus, selenate reducing Paenibacillus, west coast Bacillus, Shache Bacillus, Shackletonii Bacillus, forest soil Bacillus, simple Bacillus, silage pit Bacillus, smith Bacillus, soil Bacillus, soil mangrove Bacillus, salt soil Bacillus, Songkhla Bacillus, Sonora Desert Bacillus, spherical Bacillus, thermotolerant spore Bacillus, thermophilic Bacillus, stratosphere Bacillus, underground Bacillus, subtilis, subspecies desert, subspecies Steinernema, subspecies subspecies subspecies subspecies subspecies, Taian Bacillus, Tekila Bacillus, thermo-antartic Bacillus, thermoaerophilic Bacillus, thermo-amylophilic Bacillus, thermo-chain Bacillus, thermo-cloacae Bacillus, thermo-composting Bacillus, thermo-denitrifying Bacillus, thermo-glucosidic Bacillus, thermo-lactic Bacillus, thermo-oil-loving Bacillus Bacillus, thermophilic Bacillus, thermorhodobacterium, thermoglobose Bacillus, thiaminolyticus, sulfur-producing Bacillus, thuringiensis, Tenjin, Japanese beetle, Tusciae, strong, dead valley, Weishen, Velez, vietnamese, wild, volcanic, and light, Weishenstephanensis, Xiamen, Xiaoxi, Zhanjiang, Bacillus amyloliquefaciens NRRL B-67928, Bacillus subtilis B4 NRRL B-68031, and / or Bacillus coagulans (e.g., BC-30).
[0098] In some embodiments, the composition comprises a microbial culture supernatant to replace a pharmacological or natural therapy hair growth promoter. For example, in a specific embodiment, the composition comprises a supernatant of SLP, MEL and Bacillus (e.g., Bacillus coagulans).
[0099] Other microbial growth byproducts useful according to the present invention include mannoproteins, beta-glucans, enzymes, and other metabolites having bioemulsifying and surface / interfacial tension reducing properties.
[0100] In some embodiments, the topical cosmetic composition may include a therapeutically effective amount of enzymes and / or proteins produced by microorganisms. For example, one or more enzymes and / or proteins may be included in an amount of about 0.001 wt % to about 20 wt %, about 0.01 wt % to about 15 wt %, or about 0.05 wt % to about 10 wt %. These may include exo-β-1,3-glucanases, chitinases, esterases, lipases, glycosidases, amylases, and proteases that are beneficial to improving skin health, but are not limited thereto.
[0101] In some embodiments, the topical therapeutic composition may further comprise a dermatologically acceptable carrier or vehicle.
[0102] The carrier or vehicle may include, for example, water; saline; physiological saline; ointments; creams; oil-in-water emulsions; water-in-oil emulsions; silicone-in-water emulsions; water-in-silicone emulsions; wax-in-water emulsions; water-oil-water triple emulsions; microemulsions; gels; vegetable oils; mineral oils; ester oils such as octyl palmitate, isopropyl myristate, and isopropyl palmitate; ethers such as dicaprylyl ether and dimethyl isosorbide; alcohols such as ethanol and isopropanol; fatty alcohols such as cetyl alcohol, cetearyl alcohol, stearyl alcohol, and behenyl alcohol; isoparaffins such as isooctane, isododecane (IDD), and isobutylene glycol. Hexadecane; silicone oils, such as cyclomethicone, dimethicone, dimethicone crosspolymers, polysiloxanes and derivatives thereof, preferably organic modified derivatives, including PDMS, polydimethylsilicone copolyols, dimethicone alcohol and aminodimethicone alcohol; hydrocarbon oils, such as mineral oil, petrolatum, isoeicosane and polyolefins, such as (hydrogenated) polyisobutylene; polyols, such as propylene glycol, glycerol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol; waxes, such as beeswax, carnauba wax, ozokerite, microcrystalline wax, polyethylene wax and vegetable wax; or any combination or mixture of the foregoing substances. The aqueous vehicle may include one or more water-miscible solvents, including lower alcohols, such as ethanol, isopropanol, etc. The vehicle may account for about 1% to about 99%, about 10% to about 85%, about 25% to 75%, or about 50% to about 65% of the composition by weight.
[0103] As used herein, unless otherwise specified, the term "oil" includes silicone oil. The emulsion may include an emulsifier, such as a nonionic, anionic or amphoteric surfactant, or a gelling agent, typically in an amount of about 0.001 wt % to about 5 wt %.
[0104] In some embodiments, the topical composition may also include other adjuvants and additives commonly included in skin and hair care compositions, for example, organic solvents, stabilizers, silicones, thickeners, softeners, sunscreens, moisturizers, fragrances, or other substances described herein. The amount of each ingredient (whether active or inactive) is the amount conventionally used in the cosmetic art to achieve its intended purpose, and generally ranges from about 0.0001% to about 25% or about 0.001% to about 20% of the composition, but the amount may exceed these ranges. The nature of these ingredients and their amounts must be compatible with the production and function of the compositions of the present disclosure.
[0105] In one embodiment, the composition may include additional skin actives including, but not limited to, keratolytic agents, desquamative agents, keratinocyte proliferation promoters, collagenase inhibitors, elastase inhibitors, depigmenting agents, anti-inflammatory agents, steroids, anti-acne agents, antioxidants, and advanced glycation endproduct (AGE) inhibitors, to name a few.
[0106] In one embodiment, the composition may include anti-aging components, including but not limited to botanicals (e.g., angelica extract); phytol; phytic acid; phospholipids; silicones; petrolatum; triglycerides; ω-fatty acids; retinoids; hydroxy acids (including α-hydroxy acids and β-hydroxy acids), salicylic acid and alkyl salicylates; exfoliants (e.g., glycolic acid, 3,6,9-trioxundecanedioic acid, etc.), estrogen synthase stimulating compounds (e.g., caffeine and its derivatives); compounds capable of inhibiting 5α-reductase activity (e.g., linolenic acid, linoleic acid, finasteride and mixtures thereof); and barrier function enhancers (e.g., ceramides, glycerides, cholesterol and its esters, α-hydroxy and ω-hydroxy fatty acids and their esters).
[0107] In one embodiment, the composition can include an exfoliant. Suitable exfoliants include, for example, alpha-hydroxy acids, beta-hydroxy acids, oxa-acids, oxa-diacids and derivatives thereof, such as esters, anhydrides and salts thereof. Suitable hydroxy acids include, for example, glycolic acid, lactic acid, malic acid, tartaric acid, citric acid, 2-hydroxyalkanoic acid, mandelic acid, salicylic acid and derivatives thereof. An exemplary exfoliant is glycolic acid. When present, the exfoliant can comprise from about 0.001% to about 20% by weight of the composition.
[0108] In one embodiment, the composition may include one or more antioxidants. Suitable antioxidants include, for example, compounds with phenolic hydroxyl functions, such as ascorbic acid and its derivatives / esters; beta-carotene; catechins; curcumin; ferulic acid derivatives (e.g., ethyl ferulate, sodium ferulate); gallic acid derivatives (e.g., propyl gallate); lycopene; reducing acids; rosmarinic acid; tannic acid; tetrahydrocurcumin; tocopherol and its derivatives, including tocopherol acetate; uric acid; or any mixture thereof. Other suitable antioxidants are antioxidants with one or more thiol functional groups (--SH) in reduced or non-reduced form, such as glutathione, lipoic acid, thioglycolic acid and other sulfhydryl compounds. Antioxidants can be inorganic, such as bisulfite, metabisulfite, sulfite or other sulfur-containing inorganic salts and acids. The antioxidants may individually or collectively comprise from about 0.001% to about 10% (w / w), or from about 0.01% to about 5% (w / w), based on the total weight of the composition.
[0109] Non-biological surfactants may also be added to the formulation. Examples of surfactants include, but are not limited to, alkyl sulfates, alkyl ether sulfates (e.g., sodium / ammonium lauryl sulfate and sodium / ammonium lauryl ether sulfate), amphoteric surfactants (e.g., amphoacetates and amphopropionates), sulfosuccinates, alkyl polyglycosides, betaines (e.g., cocamidopropyl betaine (CAPB)), sulfobetaines, sarcosinates, isethionates, taurates, ethoxylated sorbitol esters, alkanolamides, and amino acid-based surfactants.
[0110] Viscosity modifiers may also be added to the composition and include, for example, cocamide DEA, oleamide DEA, sodium chloride, cellulosic polymers, polyacrylates, ethoxylated esters, alcohols, ethylene glycol, xylene sulfonates, polysorbate 20, alkanolamides, and cellulose derivatives (e.g., hydroxypropyl methylcellulose and hydroxyethyl cellulose).
[0111] Polymers may also be added and include, for example, xanthan gum, guar gum, polyquaternium-10, PEG-120 methyl glucose dioleate, PEG-150 distearate, PEG-150 polyglyceryl-2 tristearate, and PEG-150 pentaerythritol tetrastearate.
[0112] Sunscreens or combinations of sunscreens may be included to protect the skin and scalp from UVA and UVB rays. Sunscreens that can be used in the present composition include avobenzone, cinnamic acid derivatives (e.g., octyl methoxycinnamate), octylsalicylate, oxybenzone, octocrylene, titanium dioxide, zinc oxide, or any mixture thereof. Sunscreens may comprise from about 1 wt % to about 30 wt % of the total weight of the composition.
[0113] The composition can include a pH adjusting agent (e.g., citric acid, ethanolamine, sodium hydroxide, etc.) to prepare within a wide range of pH levels. In one embodiment, the pH range of the topical composition is 1.0 to 13.0. In some embodiments, the pH range of the topical composition is 2.0 to 12.0. Other pH ranges suitable for the present composition include 3.5 to 7.0, or 7.0 to 10.5. Suitable pH adjusting agents, such as sodium hydroxide, citric acid, and triethanolamine can be added to make the pH within the desired range.
[0114] The composition may optionally contain other components, additives or adjuvants known to those skilled in the art, including but not limited to: skin penetration enhancers; emollients (e.g., isopropyl myristate, petrolatum, volatile or non-volatile silicone oils, such as methyl and dimethicone, ester oils, mineral oils and fatty acid esters); humectants (e.g., glycerol, hexylene glycol, caprylyl glycol); skin plumpers (e.g., palmitoyl oligopeptides, collagen, collagen and / or glycosaminoglycan (GAG) enhancers); anti-inflammatory agents (e.g., aloe vera, biotin); flavonoids, diclofenac, salicylic acid); chelating agents (e.g., EDTA or its salts, such as disodium EDTA); vitamins (e.g., tocopherol and ascorbic acid); vitamin derivatives (e.g., ascorbyl monopalmitate, tocopheryl acetate, vitamin E palmitate); thickeners (e.g., hydroxyalkyl cellulose, carboxymethyl cellulose, carbomer and vegetable gums such as xanthan gum); gelling agents (e.g., terminal ester polyester amides); structurants; proteins; immunomodulators (e.g., corticosteroids and nonsteroidal immunomodulators).
[0115] Other ingredients that can be included include film formers, humectants, minerals, viscosity and / or rheology modifiers, insect repellents, skin cooling compounds, skin protectants, lubricants, preservatives, pearls, chromite, mica, conditioners, antiallergic agents, antimicrobial agents (e.g., antifungal agents, antiviral agents, antibacterial agents), preservatives, medicaments, light stabilizers, surface smoothing agents, optical diffusers and exfoliating accelerators. For detailed information on these and other suitable cosmetic ingredients, refer to the 10th edition (2004) 2177-2299 pages of the International Cosmetic Ingredient Dictionary and Handbook published by the Cosmetics, Toiletries and Fragrance Association (CTFA), which is incorporated herein by reference in its entirety. The amount of these various materials is the amount conventionally used in the cosmetic or pharmaceutical fields, for example, they can account for about 0.01% to about 20% of the total weight of the composition.
[0116] The composition may be formulated as a suspension, emulsion, hydrogel, multiphase solution, vesicular dispersion or any other known form of topical composition.
[0117] In certain embodiments, the topical composition can be formulated so that it can be applied by, for example, a pen, tube, bottle, brush, stick, sponge, cotton swab, towelette (wet wipes), sprayer, dropper, hand, or finger.
[0118] The composition can be formulated into various product forms, such as lotions, creams, serums, sprays, aerosols, liquid cakes, solid sticks, ointments, essences, gels, pastes, patches, cosmetic pencils, cosmetic powders, towelettes, soaps, shampoos, conditioners, sticks, foams, mousses, elixirs or concentrates. In a preferred embodiment, the composition is formulated so that it is particularly suitable for topical application to the scalp.
[0119] Ways to promote hair growth
[0120] In certain embodiments, the present invention provides methods for promoting hair growth, wherein a topical composition of the present invention is applied directly to an area of the subject's skin where hair loss occurs and / or hair growth is desired, such as the scalp, eyelids, face, limbs, or trunk.
[0121] In some embodiments, the method can enhance scalp health, prevent hair loss, and / or stimulate hair growth in a subject in need thereof. In some embodiments, the subject experiences hair loss due to model alopecia areata, chemotherapy, skin injury, burns, scarring, or a side effect of a drug.
[0122] In some embodiments, "applying" the composition can be by smearing, spraying, or otherwise contacting the composition with the skin or hair. "Skin" as referred to herein means the scalp in addition to other external parts of the body. In some embodiments, the composition is rubbed or massaged into the skin. In some embodiments, the composition is left on the skin for complete absorption, while in other embodiments, the composition is applied to the skin for a therapeutically effective amount of time and then rinsed or removed from the skin using, for example, water or a cloth.
[0123] In certain embodiments, the topical composition is applied zero to ten times per day, preferably at least once per day or at least once every other day. In some embodiments, the topical composition is applied every day or every other day for an indefinite period of time, such as at least one week, two weeks, three weeks, or longer, to achieve and / or maintain a desired level of hair growth.
[0124] In one embodiment, the composition is applied in an amount of about 0.001 to about 100 mg per square centimeter of skin, more typically about 0.01 to about 20 mg / cm 2 , or about 0.1 to about 10 mg / cm 2 However, more or less may be used, depending on the size of the skin area to be treated.
[0125] In certain embodiments, the method may further include applying an additional composition to enhance hair growth and / or supplement the activity of the topical composition as part of a hair growth regimen. For example, in one embodiment, the method may include cleaning the scalp or other area of the skin experiencing hair loss with a cleansing composition comprising a mixture of SLP and MEL.
[0126] Additional cleaning steps can be performed, for example, once a day to once a week. In certain embodiments, cleaning is performed immediately prior to applying the topical composition. In certain embodiments, cleaning is performed a few minutes to a few hours before or after applying the topical composition, for example, 5 minutes to 12 hours before or after application.
[0127] In certain embodiments, the cleaning composition comprises about 150 to 300 ppm, or about 200 ppm of SLP, comprising a 70:30 ratio of linear SLP to lactone SLP. In certain embodiments, the cleaning composition comprises about 1 to 10 ppm, or about 5 ppm of MEL.
[0128] The cleansing composition may contain other components, including, for example, carriers, moisturizers, fragrances, colorants, and other components described above with respect to topical compositions for promoting hair growth. In certain embodiments, the cleansing composition is a shampoo, conditioner, or hair tonic.
[0129] In certain embodiments, the application of topical compositions and / or cleansers can also be supplemented with the application of oral compounds, such as DHT (dihydrotestosterone) blockers or 5-α-reductase inhibitors. DHT blockers can include, for example, estradiol alfa, dutasteride, epretide, and finasteride.
[0130] DHT is an androgen derived from testosterone in men and is necessary for the development and maintenance of male sexual characteristics, such as muscle tissue and facial hair. Testosterone is converted to DHT by the enzyme 5-alpha-reductase, which is stored in the oil glands of the hair follicles. In some cases, subjects with pattern alopecia areata experience follicular atrophy due to excess DHT binding to the follicles; therefore, in some embodiments, DHT blockers can help prevent hair loss by this mechanism.
[0131] In some embodiments, an oral DHT blocker is administered to a subject daily at a dosage rate determined by a physician or pharmacist.
[0132] Advantageously, in some embodiments, use of a multi-part regimen may provide longer lasting consistent results for subjects experiencing hair loss.
[0133] Microbial growth and production of microbial growth by-products
[0134] The present invention provides methods for culturing microorganisms and producing microbial metabolites and / or other byproducts of microbial growth. "Fermentation" as used herein refers to the growth of cells under controlled conditions. Growth can be aerobic or anaerobic.
[0135] In one embodiment, the invention provides materials and methods for producing biomass (e.g., living cellular material), extracellular metabolites (e.g., small molecules and secreted proteins), residual nutrients, and / or intracellular components (e.g., enzymes and other proteins).
[0136] The microbial growth container used according to the present invention can be any fermenter or culture reactor of industrial use. In one embodiment, the container can have a functional controller / sensor, or can be connected to a functional controller / sensor to measure important factors in the culture process, such as pH, oxygen, pressure, temperature, agitator shaft power, humidity, viscosity and / or microbial density and / or metabolite concentration.
[0137] In another embodiment, the container can also monitor the growth of microorganisms within the container (e.g., measuring cell number and growth stage). Alternatively, daily samples can be removed from the container and counted by techniques known in the art (e.g., dilution plating techniques).
[0138] In one embodiment, the method comprises supplementing the culture with a nitrogen source. The nitrogen source can be, for example, potassium nitrate, ammonium nitrate, ammonium sulfate, ammonium phosphate, ammonia, urea and / or ammonium chloride. These nitrogen sources can be used alone or in combination of two or more.
[0139] The method can provide oxygenation for the growing culture. One embodiment utilizes the slow movement of air to remove low oxygen air and introduce oxygen-enriched air. The oxygen-enriched air can be ambient air that is replenished daily by a mechanism including an impeller (for mechanically agitating the liquid) and an air sparger (for providing bubbles to the liquid to dissolve oxygen into the liquid).
[0140] The method may further comprise supplementing the culture with a carbon source. The carbon source is typically: a carbohydrate, such as glucose, sucrose, lactose, fructose, trehalose, mannose, mannitol and / or maltose; an organic acid, such as acetic acid, fumaric acid, citric acid, propionic acid, malic acid, malonic acid and / or pyruvic acid; an alcohol, such as ethanol, propanol, butanol, pentanol, hexanol, isobutanol and / or glycerol; a fat and oil, such as soybean oil, rice bran oil, olive oil, corn oil, sesame oil and / or linseed oil; and the like. These carbon sources may be used alone or in combination of two or more.
[0141] In one embodiment, the growth factor and trace nutrients for microorganisms are included in the culture medium. This is particularly preferred when the culture cannot produce the microorganisms of all the vitamins required for it. Inorganic nutrients may also be included in the culture medium, including trace elements such as iron, zinc, copper, manganese, molybdenum and / or cobalt. In addition, the source of vitamins, essential amino acids and trace elements may also be included, for example, in the form of flour or meals (such as corn flour), or in the form of extracts (such as yeast extract, potato extract, beef extract, soybean extract, banana peel extract, etc.), or in a purified form. Amino acids may also be included, for example, amino acids that can be used for protein biosynthesis.
[0142] In one embodiment, inorganic salts may also be included. Available inorganic salts may be potassium dihydrogen phosphate, dipotassium hydrogen phosphate, disodium hydrogen phosphate, magnesium sulfate, magnesium chloride, ferric sulfate, ferric chloride, manganese sulfate, manganese chloride, zinc sulfate, lead chloride, copper sulfate, calcium chloride, calcium carbonate and / or sodium carbonate. These inorganic salts may be used alone or in combination of two or more.
[0143] In some embodiments, the culture method may further include adding additional acid and / or antimicrobial agents to the liquid culture medium before and / or during the culture process. Antimicrobial agents or antibiotics are used to protect the culture from contamination. In addition, defoamers may also be added to prevent the formation and / or accumulation of foam during the culture process.
[0144] The pH of the mixture should be appropriate for the target microorganism. Buffers and pH adjusters (e.g., carbonates and phosphates) can be used to stabilize the pH around the preferred value. When metal ions are present in high concentrations, it may be necessary to use chelating agents in the liquid culture medium.
[0145] Methods and apparatus for microbial cultivation and microbial byproduct production can be performed in batch, quasi-continuous or continuous processes.
[0146] In one embodiment, the culture method of the microorganism is carried out at about 5° to about 100° C., preferably 15 to 60° C., more preferably 25 to 50° C. In a further embodiment, the culture can be carried out continuously at a constant temperature. In another embodiment, the culture can be subjected to temperature changes.
[0147] In one embodiment, the method and the equipment used in the culture process are sterile.Cultivation equipment (e.g., reactor / container) can be separated from a sterilization unit (e.g., autoclave), but can be connected to the sterilization unit.Cultivation equipment can also have a sterilization unit that is sterilized on the spot before starting inoculation.Air can be sterilized by methods known in the art.For example, ambient air can pass through at least one filter before being introduced into a container.In other embodiments, the culture medium can be pasteurized, or alternatively heat is not added at all, wherein low water activity and low pH can be utilized to control bacterial growth.
[0148] In one embodiment, the invention provides methods for producing microbial metabolites by culturing the microbial strains of the invention under conditions suitable for growth and production of metabolites, including, for example, biosurfactants, enzymes and / or other proteins. The metabolite content of the resulting culture can be, for example, at least 20%, 30%, 40%, 50%, 60%, 70%, 80% or 90%.
[0149] The biomass content of the fermentation broth may be, for example, from 5 g / l to 180 g / l or more, or from 10 g / l to 150 g / l.
[0150] The microbial growth byproducts produced by the target microorganisms can be retained in the microorganisms or secreted into the liquid culture medium. In another embodiment, the method for producing microbial growth byproducts can also include the steps of concentrating and purifying the target microbial growth byproducts. In a further embodiment, the liquid culture medium can contain compounds that stabilize the activity of the microbial growth byproducts.
[0151] In one embodiment, all of the microbial culture is removed after the culture is complete (e.g., after a desired cell density or density of a particular metabolite in the culture medium is reached). In this batch procedure, after the first batch is harvested, a completely new batch is started.
[0152] In another embodiment, only a portion of the fermentation product is removed each time. In this embodiment, the biomass with living cells remains in the container as an inoculum for a new culture batch. The composition removed can be a cell-free broth or contain cells. In this way, a quasi-continuous system is created.
[0153] Advantageously, the method does not require complex equipment or high energy consumption. The target microorganism can be cultured and utilized on site on a small or large scale, even still mixed with its culture medium. Similarly, microbial metabolites can also be produced in large quantities at the location of need.
[0154] Microorganisms can be, for example, bacteria, yeasts and / or fungi. These microorganisms can be natural or genetically modified microorganisms. For example, microorganisms can be transformed with specific genes to exhibit specific characteristics. Microorganisms can also be mutants of desired strains. As used herein, "mutant" refers to a strain, genetic variant, or subtype of a reference microorganism, wherein the mutant has one or more genetic variations (e.g., point mutations, missense mutations, nonsense mutations, deletions, duplications, frameshift mutations, or repeat amplifications) compared to the reference microorganism. Procedures for making mutants are well known in the microbiology field. For example, ultraviolet mutagenesis and nitrosoguanidine are widely used for this purpose.
[0155] In certain embodiments, the microorganism is capable of producing amphiphilic molecules, enzymes, proteins and / or biopolymers. Microbial biosurfactants are specifically produced by a variety of microorganisms, such as bacteria, fungi and yeast, including, for example: Agrobacterium (e.g., Agrobacterium radiobacterium); Arthrobacter; Aspergillus; Pullulan (e.g., Pullulan); Azotobacter (e.g., Azotobacter vinelandii, Azotobacter rotundus); Azospirillum (e.g., Azospirillum brasiliensis); Bacillus (e.g., Bacillus subtilis, Bacillus amyloliquefaciens, Bacillus pumilus, Bacillus coagulans, Bacillus cereus, Bacillus licheniformis, Bacillus firmus, Bacillus laterosporus, Bacillus megaterium); Blakeslea; Candida (e.g., Candida albicans, Candida rugosa, Candida tropicalis, Candida lipolytica, Candida torulopsis); Clostridium (e.g., Clostridium butyricum, Clostridium tyrobutyricum, Clostridium acetobutylicum, Clostridium beijerinckii); Campylobacter; Corynebacterium; Cryptococcus; Debaryomyces (e.g., Debaryomyces hans; Insects
[0013] The present invention relates to the following fungi: Compositions of the genus: Flavobacterium; Gordonia; Hansenula; Hansenula sporangiophora (e.g., Hansenula viticola); Issatchenia; Kluyveromyces; Meyeria (e.g., Meyeria guilliermondii); Mortierella; Mycorrhiza; Mycobacterium; Nocardia; Pichia (e.g., Pichia anomala, Pichia guilliermondii, Pichia occidentalis, Pichia kudriavzevii); Phycomyces; Pythium; Pseudomonas (e.g., Pseudomonas aeruginosa, Pseudomonas chlororaphis, Pseudomonas putida, Pseudomonas fluorescens, Pseudomonas fragariae, Pseudomonas syringae); Pseudomonas (e.g., Pseudomonas aphidosa); Ralstonia (e.g., Ralstonia eutropha); Rhodococcus (e.g., Rhodococcus erythropolis); Rhodospirillum (e.g., Rhodospirillum rubrum); Rhizobium; Rhizopus; Saccharomyces (e.g., Saccharomyces cerevisiae, S. boulardii sequela, S. cerevisiae); Sphingomonas (e.g., S. paucimobilis); Starmosaccharomyces (e.g., Starmosaccharomyces bumblebee); Chytrid; Torulopsis; Ustilago (e.g., Ustilago maydis); Wickham's yeast (e.g., Wickham's yeast); Willis; and / or Zygosaccharomyces (e.g., Zygosaccharomyces bailii).
[0156] In one embodiment, the method utilizes yeast, such as Wickham's yeast, Pseudomonas aphidomyces, Bombus stamina, Pichia kudriavzevii or Pichia guilliermondii (Meyer yeast). These yeasts are efficient producers of various amphiphilic molecules, including glycolipids, enzymes and other useful metabolites. In a specific embodiment, the method utilizes Wickham's yeast.
[0157] Other microbial strains may be used according to the invention, including, for example, other strains capable of accumulating large amounts of, for example, amphiphilic molecules. Other metabolites useful according to the invention include mannoproteins, beta-glucans, and other molecules having bioemulsifying and surface / interfacial tension reducing properties.
[0158] Preparation of microbial-based products
[0159] A microbial-based product of the present invention is only a fermentation broth containing microorganisms and / or microbial metabolites produced by microorganisms and / or any residual nutrients. The fermentation product can be used directly without extraction or purification.
[0160] However, extraction and purification can be readily accomplished using standard extraction and / or purification methods or techniques described in the literature. For example, in certain embodiments, the microbial-based product comprises only byproducts of microbial growth, either in crude or purified form. In a particular embodiment, the byproduct is a biosurfactant produced by a microorganism grown according to the present invention.
[0161] The microorganisms and / or broth resulting from the growth of the microorganisms may be removed from the growth vessel and transferred, for example, via a piping system, for immediate use.
[0162] In other embodiments, the composition (microorganism, broth, or microorganism and broth) can be placed in a container of appropriate size, taking into account, for example, the intended use, the intended method of application, the size of the fermenter, and any mode of transportation from the microbial growth facility to the point of use. Thus, the container in which the microbial-based composition is placed can be, for example, from 1 gallon to 1000 gallons or more. In other embodiments, the container is 2 gallons, 5 gallons, 25 gallons or larger.
[0163] In certain embodiments, the compositions of the invention have advantages over, for example, biosurfactants alone, including one or more of the following: a high concentration of mannoprotein as part of the outer surface of the yeast cell wall (mannoprotein is a highly efficient bioemulsifier capable of achieving an emulsification index of up to 80%); the presence of the biopolymer β-glucan (an emulsifier) in the yeast cell wall; the presence of biosurfactants in the culture, which can reduce surface tension and interfacial tension; and the presence of metabolites (e.g., lactic acid, ethanol, etc.).
[0164] After the microorganism-based composition is harvested from the growth vessel, other components may be added while the harvested product is placed in containers and / or transported by pipeline (or otherwise transported for use). Additives may be, for example, buffers, carriers, other microorganism-based compositions produced in the same or different facilities, viscosity modifiers, preservatives, nutrients for microbial growth, tracers, solvents, biocides, other microorganisms, and other ingredients specific to the intended use.
[0165] Other suitable additives that may be included in the formulations according to the present invention include substances commonly used in such formulations. Examples of such additives include surfactants, emulsifiers, lubricants, buffers, solubility control agents, pH regulators, preservatives, stabilizers and anti-ultraviolet agents.
[0166] In one embodiment, the composition can also include a buffer, including organic acids and amino acids or their salts. Suitable buffers include citrate, gluconate, tartrate, malate, acetate, lactate, oxalate, aspartate, malonate, glucoheptonate, pyruvate, galactonate, glucarate, succinate, glutamate, glycine, lysine, glutamine, methionine, cysteine, arginine and mixtures thereof. Phosphoric acid and phosphorous acid or their salts can also be used. Synthetic buffers are suitable for use, but it is best to use natural buffers, such as the organic acids and amino acids or their salts listed above.
[0167] In another embodiment, the pH adjuster comprises potassium hydroxide, ammonium hydroxide, potassium carbonate or bicarbonate, hydrochloric acid, nitric acid, sulfuric acid, or mixtures thereof.
[0168] In one embodiment, other components may be included in the formulation, such as an aqueous formulation of a salt (eg, sodium bicarbonate or carbonate, sodium sulfate, sodium phosphate, sodium dihydrogen phosphate).
[0169] Advantageously, according to the present invention, microbial-based products may include a culture medium for the growth of microorganisms. By weight, the product may be, for example, at least 1%, 5%, 10%, 25%, 50%, 75% or 100% growth medium. By weight, the amount of biomass in the product may be, for example, any value from 0% to 100%, including all percentages therebetween.
[0170] Alternatively, the product can be stored before use. The storage time is preferably short. Thus, the storage time may be less than 60 days, 45 days, 30 days, 20 days, 15 days, 10 days, 7 days, 5 days, 3 days, 2 days, 1 day or 12 hours. In a preferred embodiment, if viable cells are present in the product, the product is stored at low temperatures, e.g., below 20° C., 15° C., 10° C. or 5° C. On the other hand, the biosurfactant composition can generally be stored at ambient temperature.
[0171] References
[0172] Park, S.; Lee, J. "Modulation of Hair Growth Promoting Effect by NaturalProducts." Pharmaceutics 2021, 13, 2163. https: / / doi.org / 10.3390 / pharmaceutics13122163
[0173] Woodward et al., “Composition of enhancing hair growth.” U.S. Patent No. 9,700,503B2.
[0174] "Composition for preventing hair loss or stimulating hair growth comprising sophorolipid as an effective component." Korean Patent No. 101931299B1
Claims
1. A topical composition comprising one or more biosurfactants and a pharmacological or naturopathic hair growth promoter, and optionally a dermatologically acceptable carrier.
2. The topical composition according to claim 1, wherein the one or more biosurfactants are glycolipids selected from sophorolipids (SLPs) and mannosylerythritol lipids (MELs).
3. A topical composition according to claim 2, comprising a mixture of SLP and MEL.
4. The topical composition according to claim 2, wherein the SLP comprises a mixture of linear SLP and lactone SLP in a ratio of 70:
30.
5. The topical composition of claim 2, comprising 100 to 250 ppm of SLP.
6. The topical composition of claim 2 comprising 1 to 10 ppm of MEL.
7. The topical composition of claim 1, wherein the pharmacological hair growth promoter is minoxidil or bimatoprost.
8. A topical composition according to claim 7 comprising 5% minoxidil.
9. The topical composition according to claim 1, comprising 200 ppm SLP, 5 ppm MEL and 5% minoxidil, wherein the SLP comprises a mixture of linear SLP and lactone SLP in a ratio of 70:
30.
10. The topical composition according to claim 1, further comprising one or more dermatological adjuvants and / or additives selected from organic solvents, silicones, pH adjusters, chelating agents, gelling agents, proteins, vitamins, emollients, oils, hydroxy acids, exfoliants, viscosity modifiers, polymers, minerals, insect repellents, lubricants, preservatives, botanicals, essential oils, clarifying agents, non-biological surfactants, antioxidants, thickeners, emollients, sunscreens, moisturizers, colorants and fragrances.
11. The topical composition according to claim 1, further comprising living or non-viable cells of a microorganism selected from the group consisting of: Wickhamella anomala NRRL Y-68030, Bombus stamina, Meyer yeast guillemot, Pseudomonas aphidomyces, Bacillus coagulans, Bacillus amyloliquefaciens NRRL B-67928, and Bacillus subtilis B4 NRRL B-68031.
12. The topical composition of claim 1, wherein the composition is formulated as a lotion, cream, gel, ointment, liquid, wipes, soap, shampoo, conditioner, tonic, mousse, foam or spray, and wherein the formulation is suitable for direct application to the skin, scalp and hair.
13. A method for promoting hair growth comprising applying a topical composition comprising SLP, MEL and a pharmacological or naturopathic hair growth promoter to an area of a subject's skin where hair growth is desired, wherein application of the topical composition results in faster hair growth compared to the use of SLP, MEL or the pharmacological or naturopathic hair growth promoter alone.
14. The method of claim 13, wherein the SLP comprises a mixture of linear SLP and lactone SLP in a ratio of 70:
30.
15. The method of claim 13, wherein the topical composition comprises 100 to 250 ppm of SLP.
16. The method of claim 13, wherein the topical composition comprises 1 to 10 ppm of MEL.
17. The method of claim 13, wherein the pharmacological hair growth promoter is minoxidil or bimatoprost.
18. The method of claim 13, wherein the topical composition comprises 5% minoxidil.
19. The method of claim 13, comprising applying 200 ppm SLP, 5 ppm MEL, and 5% minoxidil to the skin of a subject, wherein the SLP comprises a mixture of linear SLP and lactone SLP in a ratio of 70:
30.
20. The method of claim 13, wherein the subject experiences hair loss due to alopecia, chemotherapy, skin injury, burns, or a side effect of a drug.
21. The method of claim 13, wherein the area of the subject's skin to which the topical composition is applied is the scalp, eyelids, face, extremities, or trunk.
22. The method of claim 13, wherein the composition is administered once daily.
23. The method of claim 13, wherein the composition is rubbed onto an area of skin to be absorbed therein.
24. The method of claim 13, wherein the composition is left on the area of skin for a therapeutically effective amount of time and then the composition is rinsed or otherwise removed from the skin.
25. The method of claim 13, further comprising cleansing the area of skin with a cleansing composition comprising a mixture of SLP and MEL.
26. The method of claim 25, wherein the cleaning composition comprises 200 ppm SLP and 5 ppm MEL.
27. The method of claim 26, wherein the SLP comprises a mixture of linear SLP and lactone SLP in a ratio of 70:
30.
28. The method of claim 25, wherein the cleansing composition is applied immediately prior to applying the topical composition.
29. The method of claim 25, wherein the cleansing composition is applied between 5 minutes and 12 hours before or after application of the topical composition.
30. The method of claim 13, further comprising administering an oral DHT blocker to the subject once daily.
31. The method of claim 30, wherein the DHT blocker is alfaestradiol, dutasteride, apretil or finasteride.
32. A topical composition comprising one or more biosurfactants and a microbial culture supernatant, and optionally a dermatologically acceptable carrier.
33. The topical composition of claim 1, wherein the one or more biosurfactants are glycolipids selected from sophorolipids (SLPs) and mannosylerythritol lipids (MELs).
34. A topical composition according to claim 33 comprising a mixture of SLP and MEL.
35. The topical composition of claim 33, wherein the SLP comprises a mixture of linear SLP and lactone SLP in a ratio of 70:
30.
36. The topical composition of claim 33 comprising 100 to 250 ppm of SLP.
37. A topical composition according to claim 33 comprising 1 to 10 ppm of MEL.
38. The topical composition of claim 32, wherein the microbial culture supernatant is collected from a culture of Bacillus bacteria.
39. The topical composition of claim 38, wherein the Bacillus spp. is Bacillus coagulans.
40. The topical composition of claim 32, comprising 200 ppm SLP, 5 ppm MEL and Bacillus coagulans culture supernatant, wherein the SLP comprises a mixture of linear SLP and lactone SLP in a ratio of 70:
30.
41. The topical composition of claim 32 further comprising one or more dermatological adjuvants and / or additives selected from organic solvents, silicones, pH adjusters, chelating agents, gelling agents, proteins, vitamins, emollients, oils, hydroxy acids, exfoliants, viscosity modifiers, polymers, minerals, insect repellents, lubricants, preservatives, botanicals, essential oils, clarifying agents, non-biological surfactants, antioxidants, thickeners, emollients, sunscreens, moisturizers, colorants and fragrances.
42. The topical composition of claim 32, wherein the composition is formulated as a lotion, cream, gel, ointment, liquid, wipes, soap, shampoo, conditioner, tonic, mousse, foam or spray, and wherein the formulation is suitable for direct application to the skin, scalp and hair.
